MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$51,603K
EPS
-$1.71
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
44,146
14,645
9,487*
2,419
General and administrative
9,769
7,459
5,179*
2,827
Total operating loss
53,915
22,104
14,666*
5,246
Interest income
2,974
2,850
1,799*
707
Realized gain on sale of marketable securities, net
0
0
119*
0
(gain) loss on change in fair value of derivative instruments
-662
200
-1,788*
983
Total non-operating income (loss)
2,312
3,050
130*
1,690
Loss before income tax
-51,603
-19,054
-14,536*
-3,556
Income tax provision
0
0
1*
0
Net loss
-51,603
-19,054
-14,537
-3,556
Basic EPS
-1.71
-0.67
-1.414
-0.61
Diluted EPS
-1.71
-0.67
-1.414
-0.61
Basic Average Shares
30,137,733
28,241,701
10,283,428
5,806,862
Diluted Average Shares
30,137,733
28,241,701
10,283,428
5,806,862
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$51,603K
Interest income
$2,974K
Loss before income
tax
-$51,603K
Total non-operating
income (loss)
$2,312K
(gain) loss on change in
fair value of...
-$662K
Total operating loss
$53,915K
Research and development
$44,146K
General and
administrative
$9,769K
Buy us a coffee
LB PHARMACEUTICALS INC (LBRX)
LB PHARMACEUTICALS INC (LBRX)